Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Benchmark stock indices Sensex and Nifty tumbled nearly 1 per cent on Friday, marking their sixth consecutive day of decline, following heavy selling in pharma and IT shares as US President Donald Trump announced 100 per cent duties on pharmaceutical

Welspun Corp bags ₹1,600 crore orders since June 4; order book at ₹18,000 crore

Homegrown Welspun Corp Limited (WCL) on Friday (September 26) announced the receipt of a new export order for the supply of large-diameter line pipes for oil and gas applications from one of its prestigious clients in the Middle East. The

Tata Investment, Shilpa Medicare to Julien Agro: 9 stocks to watch for stock split, bonus issue in October

Retail investors are often on the lookout for stocks offering stock splits or bonus benefits, as these corporate actions can increase the number of shares held by them at no additional cost, even as the investment value remains the same.

Trump’s 100% tariff on pharma will not impact generic makers: IPA

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump’s move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines. Illustration: Yves Herman/Reuters Reacting to

NSE unique investors base crosses 12 cr; 1 in 4 are women

The unique investors’ base on the National Stock Exchange of India (NSE) crossed the 12-crore mark on September 23, with the latest 1 crore addition taking place in just eight months, the bourse said on Thursday. NSE said one in

Indian team back from US after holding trade talks

The Indian team has returned from the US after holding trade talks with their American counterparts in New York, an official said on Thursday. Illustration: Dado Ruvic/Reuters Commerce and Industry Minister Piyush Goyal, who led the team, will be back

Power sector CO2 emissions fall for second time in 50 Years

India’s power sector CO2 emissions fell in H1 2025 for the first time in nearly 50 years (outside the pandemic), thanks to record renewable growth and lower coal use from cooler, wetter weather. The decline in power sector emissions helped

Accenture Q4 Results: Revenue beats estimates, FY26 growth forecast at 2-5%

Accenture on Thursday posted fourth-quarter revenue of $17.6 billion, slightly ahead of Wall Street estimates, as strong demand for artificial intelligence-led consulting and digital services buoyed its performance. Shares of the Dublin-based IT consulting firm rose 3.7% in premarket trade.

Accenture Q4 revenue rises 7%, tops estimates on AI-led demand surge

Accenture’s fiscal fourth quarter earnings exceeded expectations, with a 7% year-over-year revenue increase to $17.6 billion, surpassing Wall Street’s estimate of $17.38 billion. Source link

Reality show to apps, Mathrubootham spreads funding wings

Within weeks of announcing his exit as executive chairman of the global software-as-a-service (SaaS) company Freshworks, its founder Girish Mathrubootham appears to be on an investment spree. Photograph via Meta On Wednesday, he invested in Baanhem Ventures, which created Tamil